Biography
My group is interested in identifying why obese individuals are at greater risk of liver injury in the setting of trauma or surgery. My long-term goal is to understand the relationship between metabolic and immunologic processes in the liver. One potential link between these underlying mechanisms could be the peptide leptin, which can profoundly modify inflammatory and metabolic pathways. The goal of this research effort is to improve understanding of the impact of leptin on acute inflammatory cascade and metabolic response during hepatic ischemia-reperfusion. This will benefit patients by improving risk-stratification of candidates for hepatic surgery and possibly lead to preventive therapies for ischemia-reperfusion injury.
Education
- 1986-93, Ludwig-Maximilians University, Munich, Germany, M.D.
- 1993-94 Intern ; City Hospital St. Georg,, University of Hamburg, Germany and Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany
- 1996-99, University of California, San Francisco, Resident, Anesthesia
- 1994-96, Department of Anesthesiology, Northwestern University, Chicago, Illinois, Fellow, Postdoctoral Research
Board Certifications
- American Board of Anesthesiology
Clinical Expertise
Pancreas Transplantation
Liver Transplantation
Kidney Transplantation
Clinical Trials
- Intensive Insulin Therapy in Deceased Donors (NCT01140035)Related Conditions: Kidney Transplant, Transplants| Start Date: | End Date:
Program Affiliations
- Department of Anesthesia and Perioperative Care
- Department of Surgery, Division of Transplantation
- UCSF Liver Center
In the News
Research Narrative
My group is interested in identifying why obese individuals are at greater risk of liver injury in the setting of trauma or surgery. My long-term goal is to understand the relationship between metabolic and immunologic processes in the liver. One potential link between these underlying mechanisms could be the peptide leptin, which can profoundly modify inflammatory and metabolic pathways. The goal of this research effort is to improve understanding of the impact of leptin on acute inflammatory cascade and metabolic response during hepatic ischemia-reperfusion. This will benefit patients by improving risk-stratification of candidates for hepatic surgery and possibly lead to preventive therapies for ischemia-reperfusion injury.
Research Interests
Inflammatory response to injuryIschemia reperfusion injury
Liver transplantation
Metabolomics
Organ donation
Renal and hepatic injury during surgery
Intensive Insulin Therapy in Deceased Donors-to improve renal allograft function and transplanted allograft outcomes
View Research Profile at UCSF Clinical & Translational Science Institute
Publications
- Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats.| | PubMed
- Glutamine does not protect against hepatic warm ischemia/reperfusion injury in rats.| | PubMed
- Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers.| | PubMed
- Metabolic profiling of livers and blood from obese Zucker rats.| | PubMed
- H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants.| | PubMed
- Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats.| | PubMed
- Ischemic preconditioning improves rat kidney graft function after severe ischemia/reperfusion injury.| | PubMed
- Automated, fast, and sensitive quantification of drugs in human plasma by LC/LC-MS: quantification of 6 protease inhibitors and 3 nonnucleoside transcriptase inhibitors.| | PubMed
- Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.| | PubMed
- Intraoperative fluid management of living donor versus cadaveric liver transplant recipients.| | PubMed